PharmGenomics GmbH is a young innovative company in the area of pharmacogenetics and individualized medicine. We specialize in the development and distribution of pharmacogenetic tests for clinical applications.
Our products are based on a new macroarray technology. This technology enables the introduction of pharmacogenetics into daily medicine for the first time.

We develop such IVD tests for a series of bio-markers in the area of DNA, mRNA and proteins.
The main advantage of this platform is the use of a non-fluorescent colometric detection method, which makes the system easy-to-handle and cost-effective. This approach is well suited for small laboratories. In addition, our system is designed for the development of highly multiplexed assays.
This new generation of macroarray chips has the following advantages compared to other systems on the market:

• Novel detection method
• Simple read-out
• Easy to handle
• Less hands-on-work time
• Very cost-effective
• Little space required

Customized Assay Development

We develop customized multiplex assays for interested companies based on the new macroarray technology. We are able to develop further easy-to-use and cost-effective point-of-care applications with this innovative technology.

Genotyping Services

We provide customers and physicians with genotyping services based on our macroarray technology as well as PCR and qRT-PCR.

Clinical Trials

Since PharmGenomics has an established collaboration with our partners in Mainz we are able to perform national and international clinical studies of phase I-IV in the area of individualized medicine.